Cited by 6Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Do Treatments for Adult ADHD Improve Emotional Behavior? A Systematic Review and Analysis

Surman, Craig B. H., Walsh, Daniel M.·2022·Journal of Attention Disorders

Abstract

Objective Dysregulated emotional behavior occurs often in adults with ADHD. Analysis of clinical trials may guide clinical intervention and future research. Method Controlled trials of adult ADHD measuring emotional behavior were included if another study offered a comparable analysis of the same treatment method. Standardized Mean Difference (SMD) of effects were calculated, and the size of effects for emotional and non-emotional ADHD behavior were compared. Results 13 out of 14 studies of methylphenidate, atomoxetine, and lisdexamfetamine demonstrated significant improvement in emotional behavior measures, with small to high SMDs. The proportional effect on emotional versus non-emotional behavior ranged from 46% to 110% for methylphenidate, 56% to 129% for atomoxetine, and 36% to 96% for lisdexamfetamine. Conclusion Psychopharmacological treatments for ADHD are likely to improve emotional behavior, and available scales are sensitive to these effects. Studies dedicated to treatment of this domain of function can further refine clinical approaches.

Integrity signals

Registry

Crossref · 10.1177/10870547221110926

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Surman, C. B. H., & Walsh, D. M.
Affiliations
  • Harvard University (US)
  • Massachusetts General Hospital (US)
Corresponding author
Surman, Craig B. H.
Venue
Journal of Attention Disorders
Published
2022-07-13
Volume
26
Issue
14
Pages
1822-1832
ISSN
  • 1087-0547 (ISSN-L)
  • 1557-1246
OpenAlex
W4285392517
Cited by
6
References
10
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1
FWCI
0.21
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Attention Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
adult ADHD, emotional behavior, emotional dysregulation, methylphenidate, atomoxetine, lisdexamfetamine, psychopharmacological treatment, standardized mean difference
MeSH terms
Atomoxetine Hydrochloride, Lisdexamfetamine Dimesylate, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Humans, Methylphenidate, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review